BRIAN METCALF,WENQING YAO,JINCONG ZHUO,COLIN ZHANG,MEIZHONG XU,CHUNHONG HE,DING-QUAN QIAN,DAVID M. BURNS,YUNLONG LI
申请号：
PT15191241
公开号：
PT3034075T
申请日:
2007.11.19
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
